2010 -
2011 Diploma Student @ Ludwig Boltzmann Institute for Cancer research
2005 -
2010 Student @
Thomas Hoffmann Education
Universität Wien
Doctor of Philosophy (Ph.D.) (Molecular Biology)
2006
-
2015
HBLVA Rosensteingasse
Engineer’s Degree (Chemistry; Biochemistry and Biotechnology)
2000
-
2005
Thomas Hoffmann Skills
mRNA
Optimization
RNAi
Crispr
Cas9
Next generation Sequencing
Cell Culture
Cell Biology
Molecular Cloning
Molecular Biology
Molecular & Cellular Biology
Western Blotting
Southern Blot
shRNA
advanced RNAi
FACS analysis
PCR
Life Sciences
Polymerase Chain Reaction (PCR)
Gene Therapy
ELISA
Mouse Models
qPCR
Thomas Hoffmann Summary
Thomas Hoffmann, based in Vienna, Austria, is currently a Chief Technology Officer at ADvantage Therapeutics Inc.. Thomas Hoffmann brings experience from previous roles at ADvantage Therapeutics Inc., Accanis and Research Institute of Molecular Pathology. Thomas Hoffmann holds a 2006 - 2015 Doctor of Philosophy (Ph.D.) in Molecular Biology @ Universität Wien. With a robust skill set that includes mRNA, Optimization, RNAi, Crispr, Cas9 and more. Thomas Hoffmann has 2 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.